What is Neuropace, Inc.'s financing cash flow?

Neuropace, Inc. (NPCE) reported financing cash flow of -$166K in Q1 2026.

How has Neuropace, Inc.'s financing cash flow changed year-over-year?

Neuropace, Inc.'s financing cash flow decreased by 100.8% year-over-year, from $21.11M to -$166K.

What is the long-term trend for Neuropace, Inc.'s financing cash flow?

Over 2 years (2021 to 2024), Neuropace, Inc.'s financing cash flow has grown at a -79.5% compound annual growth rate (CAGR), from $102.53M to $4.33M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Neuropace, Inc. NPCE Financing Cash Flow

Financing Cash Flow at other companies

MedtronicMDT

-$888M+33.9%

LivaNovaLIVN

-$94.25M-2,032%

ClearPoint NeuroCLPT

-$1.85M-35.5%

Inspire Medical SystemsINSP

-$7.48M+91.5%

Orthofix Medical Inc.OFIX

$63.97M+9,926%

ARS Pharmaceuticals, Inc.SPRY

$159K-78.1%

Other financials

Income statement

See full

Revenue$22.1M-2.0%

Gross profit$18.0M+4.1%

Operating income-$5.6M-8.2%

Net income-$6.7M-1.5%

EPS (diluted)-$0.20+4.8%

Balance sheet

See full

Cash & equivalents$15.6M-42.4%

Total debt$70.5M-3.7%

Total equity$14.5M-40.4%

Total assets$98.9M-10.3%

Cash flow

See full

Operating cash flow-$5.9M+21.1%

CapEx$117.0K+216%

Free cash flow-$6.0M+20.0%

Valuation

See full

Market cap$557.77M+63.4%

Enterprise value$612.6M+58.1%

P/S5.6×+1.6×

Profitability

See full

Gross margin78.3%+3.5pp

Operating margin-16.8%-3.5pp

Net margin-21.7%-4.5pp

FCF margin-10.3%-3.5pp

Returns & leverage

See full

Return on equity-111.4%-13.1pp

Debt / equity4.9×+1.9×

Current ratio5.4×-1.2×

Where this comes from

Reported directly by Neuropace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuropace, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neuropace, Inc.'s financing cash flow?: Neuropace, Inc. (NPCE) reported financing cash flow of -$166K in Q1 2026.
How has Neuropace, Inc.'s financing cash flow changed year-over-year?: Neuropace, Inc.'s financing cash flow decreased by 100.8% year-over-year, from $21.11M to -$166K.
What is the long-term trend for Neuropace, Inc.'s financing cash flow?: Over 2 years (2021 to 2024), Neuropace, Inc.'s financing cash flow has grown at a -79.5% compound annual growth rate (CAGR), from $102.53M to $4.33M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.